Nras
Entity.
- Evidence
- 23 documents · 7 separate publishers
- Standing
- Added automatically from coverage
- Time
- first seen 8 Jun 2026, last seen 18 Oct 2026
- Measured
- 0% of mentions say something specific about it; the rest only name it
- As of
- 19 Oct 2026
Record entry · Pubmed Targeted
Nothing reported: the record holds no registered event and no claim that names this.
23 documents · 7 publishers · 0% contain a typed assertion · last evidence 18 Oct 2026
Nras was added automatically on 19 Oct 2026 after 20 mentions across 12 sources over 17 days. 45% of that coverage came from a single subject area.
The counts themselves: counted automatically from tracked coverage on 19 Oct 2026
Reported alongside Nras
Names most often reported alongside it; bigger circles and heavier lines mean more shared documents. A dashed circle has no page of its own yet.
For developers
GET https://api.signalbureau.ai/api/registry?slug=nras
{
"slug": "nras",
"state": "active",
"detail": {
"state": "active",
"source": "ontology",
"label": "nras",
"promotedAt": "2026-10-19",
"category": "pubmed_targeted",
"evidence": {
"mentions": 20,
"sources": 12,
"days": 17,
"concentration": 0.45,
"standAloneShare": 0.913
}
}
}The record behind this page, as data. The live response also carries the registry date and version.
Open where it comes from, follow a claim or a related name, and use the trail to come back. Every step says what it is, how it stands and when. Machines read the same record.
Entity.
Cureus
Am J Case Rep
Pharmacol Res
Blockade of mutant RAS oncogenic signaling: a 2026 update. (opens the original article)
GEN
NRAS Mutations May Require Mutation-Guided Combination Therapies (opens the original article)
Front Oncol
Clin Pract
No trend and no market price are shown because neither has been measured for Nras yet. Informational only, not advice. As of 19 Oct 2026.